Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines.

The circulating cytokine concentrations following administration of subcutaneous recombinant interleukin 2 (IL-2) in combination with interferon alpha and 5-fluorouracil used to treat advanced renal cancer were studied. One patient was anephric and on dialysis, and seven had normal biochemical renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Banks, R. E., Forbes, M. A., Hallam, S., Jenkins, A., Wadhwa, M., Dilger, P., Meager, A., Thorpe, R., Bowmer, C. J., Joffe, J. K., Patel, P., Johnson, P. W., Selby, P. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223606/
https://www.ncbi.nlm.nih.gov/pubmed/9192992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223606/
https://www.ncbi.nlm.nih.gov/pubmed/9192992

Ejemplares similares